Thermo launches AAV production, digital PCR systems

By Melissa Busch, The Science Advisory Board contributing writer

September 20, 2021 -- Thermo Fisher Scientific announced that it has launched two new products. The first product is an adeno-associated virus (AAV) production system, while the second is a digital polymerase chain reaction (dPCR) system.

The Gibco AAV-MAX helper-free AAV production system aims to simplify the workflow involved in AAV vector production by delivering high viral titers using Viral Production Cells 2.0, a new, clonally documented, 293F-derived mammalian cell line.

Additionally, the company unveiled the Applied Biosystems QuantStudio Absolute Q digital PCR system, which is designed to provide highly accurate and consistent results within 90 minutes. The system uses microfluidic array technology and simpler workflows, and it was designed to improve the accuracy and consistency of data.

Thermo Fisher Scientific
Applied Biosystems QuantStudio Absolute Q digital PCR system, an integrated digital PCR solution, can be used for oncology, cell and gene therapy development, and other research applications. Image courtesy of Thermo Fisher Scientific.

The dPCR technology powering the QuantStudio Absolute Q platform is used by biotech companies and academic institutions for longitudinal monitoring of cancer-driving mutations in liquid biopsy, precise quantification of gene inserts for cell therapy development, and copy-number variation studies for earlier identification of genetic conditions in newborns, the company said.

Thermo Fisher announces new spectrometers, facility, more
Thermo Fisher Scientific announced that it is building a manufacturing facility in Tennessee. In addition, it has released a line of spectrometers and...
Thermo Fisher awarded $193M for pipette tip production
Thermo Fisher Scientific will receive $193 million in a contract award from the U.S. Department of Defense to help establish U.S. production of pipette...
Thermo Fisher commits to net-zero emissions by 2050
Thermo Fisher Scientific said it is committed to achieving net-zero carbon emissions by 2050.
Thermo Fisher reports high revenues in Q2
Thermo Fisher Scientific reported a significant revenue increase during the second quarter of 2021.
Thermo Fisher announces new suite of assays
Thermo Fisher Scientific announced a new suite of Ion Torrent Oncomine immune repertoire assays designed to detect potentially malignant clones of T cells...

Copyright © 2021

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter